Back to top
more

Labcorp (LH)

(Delayed Data from NYSE)

$234.38 USD

234.38
566,922

+5.27 (2.30%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $234.35 -0.03 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 251)

Industry: Medical - Dental Supplies

Zacks News

LabCorp, Philips Tie Up to Advance in Digital Pathology

Through the latest collaboration, LabCorp (LH) aims at strengthening its hold inthe high potential digital pathology market.

    Why You Should Retain Quest Diagnostics in Your Portfolio

    Quest Diagnostics (DGX) reveals both sides of the same coin, reflecting its bleak aspects plaguing the stock as well as projecting its brighter side to denote a near-term rebound.

      Why Is Laboratory of America Holdings (LH) Up 1.7% Since Its Last Earnings Report?

      Laboratory of America Holdings (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

        LabCorp (LH) Beats on Earnings & Revenues in Q1

        Here we have highlighted some of the key details from the just-released earnings report of Laboratory Corp. of America Holdings (LH).

          LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm

          The multi-year, comprehensive laboratory deal to help LabCorp (LH) provide high-quality, high-value and standardized laboratory diagnostics for Appalachian Regional Healthcare.

            Is Laboratory Corporation (LH) a Great Stock for Value Investors?

            Is Laboratory Corporation (LH) a great pick from the value investor's perspective right now? Read on to know more.

              LabCorp (LH) Up 1.1% Since Earnings Report: Can It Continue?

              LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                LabCorp (LH) Tops Q4 Earnings & Misses Revenue Estimates

                LabCorp (LH) witnessed year over year growth in net revenue on the back of both LabCorp Diagnostics and Covance Drug Development segment in Q4.

                  LabCorp (LH) Beats on Q3 Earnings & Revenue Estimates

                  LabCorp (LH) rides high on both LabCorp Diagnostics segment and Covance Drug Development segment in Q3.

                    What's in the Cards for LabCorp (LH) This Earnings Season?

                    LabCorp (LH) might gain from continued growth in its companion diagnostics portfolio in Q3.

                      Should Value Investors Pick Laboratory Corporation (LH) Stock?

                      Is Laboratory Corporation (LH) a great pick from the value investor's perspective right now? Read on to know more.

                        LabCorp Completes $1.2-Billion Chiltern Buyout, Boosts CRO

                        In line with its inorganic growth strategy, LabCorp's (LH) latest Chiltern buyout is aimed at promoting the CRO business.

                          LabCorp (LH) Beats on Q2 Earnings and Revenue Estimates

                          Laboratory Corp. of America Holdings (LH) rides high on its Diagnostics business Q2. The raised outlook buoys optimism.

                            Urmimala Biswas headshot

                            LabCorp (LH) Tops Q1 Earnings, Misses Revenue Estimate

                            LabCorp has a Zacks Rank #4(Sell) but that could change following its first quarter 2017 earnings report which has just released.

                              Is Laboratory Corp. a Suitable Stock For Value Investors?

                              Let's put Laboratory Corporation Of America Holdings (LH) stock into this equation and find out if it is a good choice for value-oriented investors right now.

                                LabCorp (LH) Up 3.6% Since Earnings Report: Can It Continue?

                                LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                  LabCorp (LH) Beats on Q4 Earnings & Revenue Estimates

                                  LabCorp posted fourth quarter 2016 results with both earnings and revenues beating the Zacks Consensus Estimate.

                                    MedTech Stocks' Q4 Earnings on Feb 16: LH, WST and MDRX

                                    Let's take a look at the major MedTech stocks slated to release their fourth-quarter 2016 numbers on Feb 16.

                                      Lots Happening in MedTech: Should You Buy These Stocks?

                                      We have noticed a substantial transformation in the U.S. medical device market of late and it is important for market participants to adapt. We have hit upon3 major evolving trends in this sector.

                                        Brian Bolan headshot

                                        3 Stocks That Beat Earnings and Raised This Week

                                        The beat and raise is music to the ears of the aggressive growth investor.